Serina Therapeutics (SER) Minority Interest (2017 - 2025)
Serina Therapeutics (SER) posted Minority Interest of -$166000.0 for Q3 2025, down 6.41% sequentially from -$156000.0 in Q2 2025, and down 207.41% YoY from $154551.7 in Q3 2024.
Serina Therapeutics (SER) Minority Interest (2017 - 2025) Analysis & Trends
Serina Therapeutics has reported Minority Interest for 9 years, with the latest figure at -$166000.0 in Q3 2025.
- Quarterly Minority Interest fell 207.41% year-over-year to -$166000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$166000.0 (down 207.41% YoY) and the FY2024 annual result came in at -$133000.0, down 100.37% from the prior year.
- Minority Interest retreated to -$166000.0 in Q3 2025 per SER's latest filing, from -$156000.0 in the prior quarter.
- Over five years, Minority Interest peaked at $36.4 million in Q4 2023 and troughed at -$166000.0 in Q3 2025.
- A 5-year average of $1.9 million and a median of -$49500.0 in 2022 frame the typical range for Minority Interest.
- The sharpest annual moves came in 2023 and 2025: Minority Interest jumped 35443.69% in 2023, then sank 420.0% in 2025.
- Over 5 years, Minority Interest stood at -$43000.0 in 2021, then plunged by 139.53% to -$103000.0 in 2022, then surged by 35443.69% to $36.4 million in 2023, then plunged by 100.37% to -$133000.0 in 2024, then decreased by 24.81% to -$166000.0 in 2025.
- According to Business Quant data, Minority Interest over the past three periods registered -$166000.0, -$156000.0, and -$142000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.09 Bn | 131.23 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.66 Bn | 77.66 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.86 Bn | 59.67 Bn | 1.37 Bn |
| 4 | Moderna | 58.07 Bn | 52.93 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.87 Bn | 36.77 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.45 Bn | 28.15 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - |
| 10 | Serina Therapeutics | 45.39 Mn | 22.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -166,000.00 |
| Jun 30, 2025 | -156,000.00 |
| Mar 31, 2025 | -142,000.00 |
| Dec 31, 2024 | -133,000.00 |
| Sep 30, 2024 | -54,000.00 |
| Jun 30, 2024 | -30,000.00 |
| Dec 31, 2023 | 36.40 Mn |
| Sep 30, 2023 | -109,000.00 |
| Jun 30, 2023 | -121,000.00 |
| Mar 31, 2023 | -111,000.00 |
| Dec 31, 2022 | -103,000.00 |
| Sep 30, 2022 | -45,000.00 |
| Jun 30, 2022 | -44,000.00 |
| Mar 31, 2022 | -44,000.00 |
| Dec 31, 2021 | -43,000.00 |
| Sep 30, 2021 | -42,000.00 |
| Jun 30, 2021 | -42,000.00 |
| Mar 31, 2021 | -41,000.00 |
| Dec 31, 2020 | -280,000.00 |
| Sep 30, 2020 | -95,000.00 |